Revelation Biosciences (REVB)
(Delayed Data from NSDQ)
$2.18 USD
+0.04 (1.87%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $2.18 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 5/27/24 |
---|---|
Current Quarter | -5.39 |
EPS Last Quarter | -8.33 |
Last EPS Surprise | 23.86% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -20.32 |
Next Year | -18.88 |
EPS (TTM) | -43.47 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -5.39 | -5.18 | -20.32 | -18.88 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -5.39 | -5.18 | -20.32 | -18.88 |
High Estimate | -1.77 | -1.36 | -4.91 | -3.25 |
Low Estimate | -9.00 | -9.00 | -35.73 | -34.50 |
Year ago EPS | -15.32 | -7.51 | -36.96 | -20.32 |
Year over Year Growth Est. | 64.82% | 31.03% | 45.02% | 7.11% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -5.39 | -5.18 | -20.32 | -18.88 |
7 Days Ago | -5.39 | -5.18 | -20.32 | -18.88 |
30 Days Ago | -5.39 | -5.18 | -20.32 | -18.88 |
60 Days Ago | -10.96 | -10.51 | -46.25 | -57.51 |
90 Days Ago | -10.96 | -10.51 | -46.25 | -57.51 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -5.39 | -5.18 | -20.32 | -18.88 |
Zacks Consensus Estimate | -5.39 | -5.18 | -20.32 | -18.88 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -8.33 | -12.31 | -7.51 | -15.32 | NA |
Estimate | -10.94 | -9.01 | -9.91 | -19.52 | NA |
Difference | 2.61 | -3.30 | 2.40 | 4.20 | 1.48 |
Surprise | 23.86% | -36.67% | 24.24% | 21.54% | 8.24% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more